Na Guan Selected Research

Na Guan Research Topics

Disease

9	Proteinuria 01/2018 - 04/2004
4	Hereditary Nephritis (Alport Syndrome) 01/2016 - 04/2008
3	Neoplasms (Cancer) 11/2022 - 08/2006
3	Wounds and Injuries (Trauma) 01/2022 - 12/2020
3	Urolithiasis 12/2010 - 03/2009
3	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2004 - 11/2003
2	Hearing Loss (Hearing Impairment) 01/2016 - 12/2014
2	Fever (Fevers) 12/2014 - 12/2010
2	Hemolytic-Uremic Syndrome 04/2012 - 04/2012
2	Nephrosis 09/2004 - 04/2004
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Inflammation (Inflammations) 08/2021
1	Thrombosis (Thrombus) 12/2020
1	Albuminuria 01/2020
1	Dent Disease 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2018
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2015
1	Hyperplasia 04/2015
1	Exanthema (Rash) 12/2014
1	Aseptic Meningitis 12/2014
1	Hypersensitivity (Allergy) 12/2014
1	Urticaria (Hives) 12/2014
1	Disease Resistance 11/2014
1	Atypical Hemolytic Uremic Syndrome 03/2014
1	Glomerulonephritis 04/2013
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2013
1	Nephrolithiasis 11/2011
1	Infections 09/2011
1	Vomiting 12/2010
1	Diarrhea 12/2010
1	AIDS-Related Complex (ARC) 11/2009
1	Urinary Calculi (Urinary Calculus) 03/2009
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 12/2007
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2007
1	Leukemia 09/2006
1	Prostatic Neoplasms (Prostate Cancer) 09/2006
1	Sclerosis 11/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2004
6	nephrinIBA 01/2009 - 11/2003
6	NPHS2 proteinIBA 05/2006 - 11/2003
4	melamineIBA 11/2011 - 03/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2009
3	Puromycin AminonucleosideIBA 11/2009 - 04/2004
3	ActininIBA 09/2004 - 11/2003
2	Biocompatible Materials (Biomaterials)IBA 01/2022 - 08/2021
2	SteroidsIBA 12/2020 - 12/2007
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 01/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 01/2016
2	Complement Factor H (Factor H)IBA 03/2014 - 04/2012
2	Collagen Type IV (Type IV Collagen)IBA 11/2008 - 04/2008
2	CalpainIBA 09/2006 - 08/2006
2	Messenger RNA (mRNA)IBA 09/2004 - 04/2004
1	catch-relaxing peptide (Mytilus)IBA 10/2023
1	Monomeric GTP-Binding ProteinsIBA 11/2022
1	PolymersIBA 08/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2018
1	Thrombopoietin (c-mpl Ligand)IBA 07/2018
1	Inosine Triphosphate (ITP)IBA 07/2018
1	CalciumIBA 01/2018
1	CollagenIBA 01/2016
1	Minocycline (Cyclops)FDA LinkGeneric 06/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2015
1	SaponinsIBA 04/2015
1	Estrogens (Estrogen)FDA Link 04/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014
1	C-Reactive ProteinIBA 12/2014
1	Leucine (L-Leucine)FDA Link 11/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2014
1	NucleotidesIBA 11/2014
1	Leucine-Rich Repeat ProteinsIBA 11/2014
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2013
1	CreatinineIBA 04/2013
1	Complement System Proteins (Complement)IBA 04/2012
1	AutoantibodiesIBA 04/2012
1	HypoxanthineIBA 11/2011
1	Proline (L-Proline)FDA Link 11/2011
1	Biomarkers (Surrogate Marker)IBA 11/2011
1	Peptides (Polypeptides)IBA 09/2011
1	PowdersIBA 12/2010
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	Prednisone (Sone)FDA LinkGeneric 01/2009
1	AntigensIBA 11/2008
1	Peptide Hydrolases (Proteases)FDA Link 11/2008
1	Protein Isoforms (Isoforms)IBA 09/2008
1	ParaffinIBA 04/2008
1	calpain inhibitorsIBA 09/2006
1	AldehydesIBA 09/2006
1	m-calpainIBA 09/2006
1	Cysteine (L-Cysteine)FDA Link 08/2006
1	EndopeptidasesIBA 08/2006

Therapy/Procedure

4	Therapeutics 12/2020 - 04/2012